ℹ️
🇬🇧
Search
Search for people relevant for "hodgkin lymphoma"
hodgkin lymphoma
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. David Belada Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
350 publications
Publications
publication
Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma
2011 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
publication
Treatment of patients with relapsed/refractory Hodgkin lymphoma
2011 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Staging of non-Hodgkin's lymphoma - Recommendations of the Czech Lymphoma Study Group
2010 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
publication
Maintenance therapy with rituximab for non-Hodgkin's lymphoma - opportunities in 2010
2010 |
Faculty of Medicine in Hradec Králové
publication
Epidemiology of non-Hodgkin's lymphomas in Czech Republic, Europe and North America
+1
2009 |
Publication without faculty affiliation
publication
The non-Hodkgin's lymphoma subtypes distribution and survival in Czech Republic
+1
2007 |
Publication without faculty affiliation
publication
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
2024 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
Load more publications (340)
Loading network view...